Global Cord Blood Banking Service Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 2.90 Billion |
 Market Size (Forecast Year) |
USD 6.80 Billion |
 CAGR |
% |
| Major Markets Players |
Global Cord Blood Banking Service Market Segmentation, By Storage Services (Public, Private, and Hybrid), Component (Cord Blood and Placenta), Application (Cancers and Blood Disorders), End-User (Hospitals and Pharmaceutical Research) – Industry Trends and Forecast to 2032
Cord Blood Banking Service Market Analysis
The cord blood banking service market has been growing steadily due to increased awareness of the therapeutic potential of stem cells umbilical cord blood. These cells are used for treating various medical conditions, including cancers, blood disorders, and immune system diseases. The market is driven by rising healthcare awareness, advancements in stem cell research, and the expanding use of cord blood in regenerative medicine. Recent developments in the market include the introduction of more advanced storage techniques, such as cryopreservation, which ensure the long-term viability of stem cells. Furthermore, increased investment in research and development is advancing the therapeutic applications of cord blood. Key market players are also expanding their services globally, leading to greater accessibility. The market faces challenges such as high storage costs and limited awareness in emerging economies but continues to grow as the demand for stem cell therapies rises.
Cord Blood Banking Service Market Size
The global cord blood banking service market size was valued at USD 2.90 billion in 2024 and is projected to reach USD 6.80 billion by 2032, with a CAGR of 11.23% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Cord Blood Banking Service Market Trends
“Innovations in Cryopreservation Technology”
The cord blood banking service market is experiencing significant growth due to increasing awareness of the medical benefits of stem cells in treating various diseases. Innovations in cryopreservation technology and storage techniques have enhanced the long-term viability of cord blood, expanding its use in regenerative medicine. One key trend is the growing adoption of private cord blood banking, as more parents opt to store their newborn's stem cells for potential future medical needs. This trend is driven by advancements in personalized medicine and stem cell therapies, which promise more treatment options for conditions such as leukemia, anemia, and genetic disorders. Overall, the market is expanding as the therapeutic potential of cord blood continues to be recognized globally, with increasing investments in research and infrastructure.
Report Scope and Cord Blood Banking Service Market Segmentation
|
Attributes |
Cord Blood Banking Service Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Key Market Players |
CBR Systems, Inc. (U.S.), Americord Registry (U.S.), Cordlife (Singapore), Cryo-Cell International, Inc. (U.S.), ViaCord (U.S.), Precision Cellular Storage Ltd. (Canada), Global Cord Blood Corporation (China), 21st Century Medicine (U.S.), America’s Blood Centers (U.S.), Canadian Blood Services (Canada), Takeda Pharmaceutical Company Limited (Japan), Shanghai RAAS Blood Products Co., Ltd. (China), Macopharma (France), Haemonetics Corporation (U.S.), Abbott (U.S.), and Beckman Coulter, Inc. (U.S.) |
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
Cord Blood Banking Service Market Definition
Cord blood banking service involves the collection, processing, and storage of stem cells from a newborn's umbilical cord blood. These stem cells are valuable for treating various medical conditions, such as blood disorders and immune diseases. The stored cord blood can be used in stem cell transplants and regenerative medicine, offering potential therapeutic benefits for the donor or others in need.
Cord Blood Banking Service Market Dynamics
Drivers
- Rising Prevalence of Autoimmune Diseases
As the prevalence of chronic diseases such as cancers, blood disorders, and autoimmune diseases continues to rise, the demand for alternative and effective treatment options has also increased. Stem cell therapy, particularly those using cord blood, offer promising solutions for treating these conditions by regenerating damaged tissues and restoring normal cell function. The potential of cord blood stem cells in treating a wide range of chronic illnesses, including leukemia, lymphoma, and sickle cell anemia, has driven greater interest in cord blood banking. This growing need for alternative treatments is a key driver of the cord blood banking service market, spurring increased demand for both public and private storage options.
- Technological Innovations in Stem Cell Treatments
Advances in gene editing technologies, particularly CRISPR, along with other innovations in stem cell research, have significantly enhanced the therapeutic potential of cord blood. These technologies enable precise modifications to stem cells, improving their ability to treat a broader range of genetic disorders, cancers, and other conditions. As gene editing techniques allow for more targeted and effective treatments, the demand for cord blood, as a source of stem cells, has risen. This progress in genetic engineering and stem cell therapies is driving the growth of the cord blood banking service market, as families and healthcare providers increasingly recognize its value for future medical applications.
Opportunities
- Expanding Clinical Applications
The growing recognition of the diverse clinical applications of cord blood, including regenerative medicine, gene therapy, and tissue engineering, presents a significant market opportunity. As research into stem cell therapies advances, cord blood is increasingly seen as a valuable resource for treating a wide range of conditions, such as organ regeneration, genetic disorders, and tissue repair. The potential to use cord blood-derived stem cells in personalized medicine, along with advancements in gene therapy, has expanded its therapeutic reach. This broader range of applications opens up new opportunities for cord blood banking services, boosting demand from both healthcare providers and families seeking long-term medical solutions.
- Improved Storage Technology
Advancements in cryopreservation and storage techniques have significantly improved the long-term viability of cord blood, making it a more reliable and trusted option for future medical use. Enhanced preservation methods ensure that stem cells retain their potency and therapeutic potential even after years of storage, which is crucial for patients relying on cord blood for future treatments. These innovations increase the confidence of parents and healthcare providers in cord blood banking and open up new market opportunities as the demand for stored stem cells for regenerative medicine, transplants, and gene therapies continues to grow.
Restraints/Challenges
- Competition from Alternative Stem Cell Sources
The increasing use of alternative stem cell sources, such as adult stem cells and induced pluripotent stem cells (iPSCs), presents a challenge to the cord blood banking market. As these alternative stem cell sources gain popularity due to their ability to be reprogrammed or harvested without ethical concerns, they may divert both attention and investment away from cord blood banking. In addition, adult stem cells and iPSCs are seen as potentially more versatile, which could reduce the demand for cord blood as a primary source of stem cells. This shift in focus from cord blood to other stem cell sources could slow the growth of the cord blood banking service market.
- High Storage Costs
The cost of storing cord blood remains a significant restraint in the cord blood banking market, particularly for private cord blood banks. The expenses associated with collection, processing, and annual storage fees can be prohibitive for many families, especially those with lower incomes. These costs create a barrier to access, limiting the number of individuals who can afford to store cord blood for potential future medical use. As a result, many families may forgo cord blood banking or opt for public banks, where the options are more limited. This financial limitation can hinder the market's growth, especially in regions with less disposable income.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Cord Blood Banking Service Market Scope
The market is segmented on the basis of storage services, component, application, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Storage Services
- Public
- Private
- Hybrid
Component
- Cord Blood
- Placenta
Application
- Cancers
- Blood Disorders
End-User
- Hospitals
- Pharmaceutical Research
Cord Blood Banking Service Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, storage services, component, application, and end-user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America leads the cord blood banking services market, driven by a high number of private sector players and strong public awareness. Europe follows as the second-largest market, fueled by significant healthcare spending and growing awareness of the benefits of cord blood banking. Both regions are witnessing increased demand for these services due to better access to healthcare and rising consumer knowledge.
The Asia-Pacific region is projected to experience significant growth from 2025 to 2032, driven by emerging economies such as China, Japan, India, and Hong Kong. Increased investments in the healthcare sector across these countries are expected to further fuel market expansion. The growing demand for advanced healthcare services and rising awareness of cord blood banking are key factors contributing to this growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Cord Blood Banking Service Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Cord Blood Banking Service Market Leaders Operating in the Market Are:
- CBR Systems, Inc. (U.S.)
- Americord Registry (U.S.)
- Cordlife (Singapore)
- Cryo-Cell International, Inc. (U.S.)
- ViaCord (U.S.)
- Precision Cellular Storage Ltd. (Canada)
- Global Cord Blood Corporation (China)
- 21st Century Medicine (U.S.)
- America’s Blood Centers (U.S.)
- Canadian Blood Services (Canada)
- Takeda Pharmaceutical Company Limited (Japan)
- Shanghai RAAS Blood Products Co., Ltd. (China)
- Macopharma (France)
- Haemonetics Corporation (U.S.)
- Abbott (U.S.)
- Beckman Coulter, Inc. (U.S.)
Latest Developments in Cord Blood Banking Service Market
- In March 2024, Cryo-Cell announced the spin-off of its subsidiary, Celle Corp., in a strategic move to enhance shareholder value. This decision aims to unlock new growth opportunities and streamline operations for both entities. The spin-off is expected to allow each company to focus on its core business, creating greater value for investors and stakeholders
- In February 2024, CooperSurgical®, a leader in fertility and women’s health, teamed up with Fulgent Genetics, Inc., a technology-driven company specializing in clinical diagnostics and therapeutic development. The partnership aims to provide families of Cord Blood Registry® (CBR®) with exclusive newborn genetic screening panels. This collaboration enhances CBR®'s offerings by incorporating advanced genetic testing, helping families make informed decisions about their children's health
- In February 2023, Americord, a prominent private stem cell bank, announced the successful release of cord blood stem cells to treat a client's grandmother in India for motor neuron disease. This progressive neurological disorder presents significant challenges for patients and their families. The use of cord blood stem cells in this case highlights the potential of stem cell therapies to offer innovative treatment options for complex health conditions
- In September 2023, CooperSurgical, a global leader in fertility and women's health, highlighted the significant role of Cord Blood Registry® (CBR®) at the annual Cord Blood Connect meeting, held from September 8th to 11th. This event, organized by the Cord Blood Association, brought together key stakeholders to promote both public and private newborn stem cell preservation. The Cord Blood Association, a nonprofit organization, works to advance the use of cord blood and birthing tissues in medical treatments, benefiting patients and advancing scientific progress
- In April 2022, Global Cord Blood Corporation revealed its plans to acquire Cellenkos, Inc., aiming for a 100% acquisition. The deal included the rights to develop and commercialize both current and future products, excluding those related to Cellenkos's ongoing collaboration with Incyte Corporation. This strategic acquisition is expected to enhance Global Cord Blood’s portfolio and expand its capabilities in stem cell-based therapies
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
